Header

UZH-Logo

Maintenance Infos

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA


Stradling, J R; Craig, S E; Kohler, M; Nicoll, D; Ayers, L; Nunn, A J; Bratton, D J (2015). Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA. Thorax, 70(2):181-182.

Abstract

The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6 months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values >0.13).
TRIAL REGISTRATION NUMBER: ISRCTN 34164388.

Abstract

The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6 months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values >0.13).
TRIAL REGISTRATION NUMBER: ISRCTN 34164388.

Statistics

Citations

16 citations in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 09 Jan 2015
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Pneumology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2015
Deposited On:09 Jan 2015 16:08
Last Modified:08 Dec 2017 09:38
Publisher:BMJ Publishing Group
ISSN:0040-6376
Publisher DOI:https://doi.org/10.1136/thoraxjnl-2014-205958
PubMed ID:25182045

Download